Test Price
2,800 AED✅ Home Collection Available
COL2A1 Gene Platyspondylic Skeletal Dysplasia, Torrance Type Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين COL2A1 لتشوه الهيكل العظمي الفقاري المسطح، نوع تورانس في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Diagnostic Confidence
99.9% Diagnostic Sensitivity via ISO 15189 & ISO 9001:2015 Accredited NGS Processing. Full gene coverage with 100x mean depth.
Premium Home Collection
Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Logistics. VIP Mobile Phlebotomy available 8 AM – 11 PM daily.
Clinical Guidance & Insurance
Telephonic Post-Test Clinical Guidance by DHA-Licensed Genetic Counselors. Direct Insurance Billing Verification via WhatsApp: +971 54 548 8731.
ملخص تنفيذي: يوفر هذا الاختبار الجيني المتقدم الكشف الدقيق عن الطفرات في جين COL2A1 المرتبطة بخلل التنسج الفقاري المسطح من نوع تورانس، معتمداً على تقنية التسلسل الجيني من الجيل التالي (NGS) وفق أعلى معايير هيئة الصحة بدبي واللوائح الاتحادية لدولة الإمارات.
Clinical Test Overview & Comparison
The COL2A1 gene test definitively diagnoses Torrance-type platyspondylic skeletal dysplasia, a rare autosomal dominant disorder characterized by severe vertebral flattening and metaphyseal irregularities, using Next-Generation Sequencing with deletion/duplication analysis. Below is a head-to-head comparison against common alternative approaches.
| Feature | Our NGS Test (Platyspondylic Torrance) | Closest Alternative (Single Gene Sanger) |
|---|---|---|
| Methodology | NGS (Full Gene + CNV Analysis) | Sanger Sequencing (Targeted Exons Only) |
| Detection Rate | >99.5% for SNVs, Indels, Large Deletions/Duplications | ~85% (misses deep intronic & large CNVs) |
| Turnaround Time | 3–4 Weeks (Comprehensive Report) | 4–6 Weeks (Often outsourced) |
| Clinical Utility | Differentiates Torrance from other COL2A1 phenotypes (e.g., SED congenita) | May misclassify due to incomplete locus coverage |
Physician Insight & Safety Mandate
“A positive COL2A1 result confirms the molecular diagnosis of Torrance dysplasia, but must always be correlated with the patient’s full clinical and radiological phenotype. This test empowers families with definitive answers, yet careful genetic counseling is essential to discuss recurrence risks and guide management. Never interpret this result in isolation.”
— Dr. Prabhakar Reddy, DHA License: 61713011
⚠ Medication & Clinical Warning
Do not discontinue or adjust any prescribed medication, especially hormonal therapies or supplements, without consulting your treating physician. This genetic test is for diagnostic confirmation only and does not replace ongoing clinical care.
- Safety Exclusion Criteria: Active fever or infection at time of blood draw may delay collection; patients on chronic anticoagulation require additional post-phlebotomy monitoring.
- Emergency Red Flags: If the patient (< 12 years) develops acute respiratory distress, severe bone pain, or spinal cord compression symptoms, seek immediate emergency medical attention — these are not test-related but disease-associated urgencies.
- Minor Consent: As per UAE CDS Law 2026 (Minors), genetic testing for individuals under 18 requires explicit parental/guardian consent and mandatory genetic counseling documentation.
Patient FAQ & Clinical Guidance
1. How accurate is the COL2A1 NGS for Torrance dysplasia, and can it detect all mutations?
Our NGS assay covers 100% of the COL2A1 coding exons, flanking intronic regions, and known deep intronic variants, achieving >99.5% analytical sensitivity and specificity for point mutations, small insertions/deletions, and large copy number changes. يغطي اختبارنا الكامل جميع الإكسونات المشفرة لجين COL2A1 مع حساسية تحليلية تزيد عن 99.5% للطفرات النقطية والتغيرات في عدد النسخ.
2. What sample types are accepted, and how should I prepare my child for blood collection at home?
We accept whole blood (3–5 mL in EDTA tube), extracted DNA, or a single drop of blood on an FTA card — all stored in ISO-certified cold-chain transport during home collection between 8 AM and 11 PM; no fasting is required, but the patient must be afebrile for 24 hours prior. يتم قبول عينات الدم الكامل أو الحمض النووي المستخلص أو قطرة دم واحدة على بطاقة FTA، مع توفر خدمة السحب المنزلي المعتمدة دون الحاجة للصيام.
3. How do I receive the result, and what clinical support is offered afterwards?
A secure digital report is delivered within 3–4 weeks, accompanied by a telephonic consultation with a DHA-licensed genetic counselor who will explain the findings, correlate them with the provided clinical history, and recommend further specialist follow-up if needed. يتم تسليم التقرير الرقمي في غضون 3 إلى 4 أسابيع متبوعاً باستشارة هاتفية مع مستشار وراثي مرخص لتفسير النتائج وربطها بالتاريخ السريري.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians